These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6317613)
21. Mechanisms involved in organ-specific autoimmune diseases. Boitard C Ann Med Interne (Paris); 1999 Apr; 150(3):213-20. PubMed ID: 10445093 [No Abstract] [Full Text] [Related]
22. Histochemical characteristics and significance of cell receptors in biology and pathology. Stumpf WE Acta Histochem Suppl; 1984; 29():23-33. PubMed ID: 6326187 [No Abstract] [Full Text] [Related]
23. Receptors, antibodies and disease. Ciba Found Symp; 1982; (90):1-312. PubMed ID: 6291878 [No Abstract] [Full Text] [Related]
24. Mutations in G proteins and G protein-coupled receptors in endocrine disease. Spiegel AM J Clin Endocrinol Metab; 1996 Jul; 81(7):2434-42. PubMed ID: 8675557 [No Abstract] [Full Text] [Related]
25. Cell receptors in disease. Jacobs S; Cuatrecasas P N Engl J Med; 1977 Dec; 297(25):1383-6. PubMed ID: 200842 [No Abstract] [Full Text] [Related]
26. [Insulin and its cellular receptors in changes in glucose metabolism]. de Pabio F; Roth J; Hedo JA Rev Clin Esp; 1981 Aug 15-31; 162(3-4):79-88. PubMed ID: 7031791 [No Abstract] [Full Text] [Related]
32. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Pasterkamp G; Van Keulen JK; De Kleijn DP Eur J Clin Invest; 2004 May; 34(5):328-34. PubMed ID: 15147329 [TBL] [Abstract][Full Text] [Related]
33. Insulin receptor degradation is accelerated in cultured lymphocytes from patients with genetic syndromes of extreme insulin resistance. McElduff A; Hedo JA; Taylor SI; Roth J; Gorden P J Clin Invest; 1984 Oct; 74(4):1366-74. PubMed ID: 6480829 [TBL] [Abstract][Full Text] [Related]
34. The role of FLT3 in haematopoietic malignancies. Stirewalt DL; Radich JP Nat Rev Cancer; 2003 Sep; 3(9):650-65. PubMed ID: 12951584 [TBL] [Abstract][Full Text] [Related]
35. Receptor databases and computational websites for ligand binding. Rana BK; Insel PA Methods Mol Biol; 2005; 306():1-15. PubMed ID: 15867461 [No Abstract] [Full Text] [Related]
36. Mechanisms of disease: the adrenocorticotropin receptor and disease. Clark AJ; Metherell LA Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):282-90. PubMed ID: 16932299 [TBL] [Abstract][Full Text] [Related]
37. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Masuda Y; Takatsu Y; Terao Y; Kumano S; Ishibashi Y; Suenaga M; Abe M; Fukusumi S; Watanabe T; Shintani Y; Yamada T; Hinuma S; Inatomi N; Ohtaki T; Onda H; Fujino M Biochem Biophys Res Commun; 2002 Apr; 293(1):396-402. PubMed ID: 12054613 [TBL] [Abstract][Full Text] [Related]
38. [Regulation of insulin receptor expression and its place in the mechanism of insulin action]. Bezdrobnyĭ IuV Usp Sovrem Biol; 1981; 92(1):35-48. PubMed ID: 7027664 [No Abstract] [Full Text] [Related]
39. Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. Crimmins NA; Martin LJ Obes Rev; 2007 Sep; 8(5):419-23. PubMed ID: 17716299 [TBL] [Abstract][Full Text] [Related]
40. Spontaneous hypoglycaemia in the presence of both anti-insulin antibody and anti-insulin receptor antibody. Bortolotti D; Mothe-Satney I; Ferrari P; Gautier N; Sonke J; Pallé S; Bernard G; Badetti JL; Fredenrich A; Van Obberghen E; Canivet B Diabetes Metab; 2006 Dec; 32(6):598-603. PubMed ID: 17296513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]